Hologic (NASDAQ:HOLX – Get Free Report) updated its third quarter 2024 earnings guidance on Friday. The company provided EPS guidance of 0.980-1.050 for the period, compared to the consensus EPS estimate of 1.020. The company issued revenue guidance of $992.5 million-$1.0 billion, compared to the consensus revenue estimate of $1.0 billion. Hologic also updated its […]
Related Keywords
Scottt Garrett , Raymond James , William Blair , Charlesj Dockendorff , Securities Exchange Commission , Jpmorgan Chase Co , Skeletal Health , Hologic Company Profile , Hologic Inc , Needham Company , Breast Health , Get Free Report , Moderate Buy , Director Charles , Director Scott , Exchange Commission , Panther Fusion , Thinprep System , Rapid Fetal Fibronectin Test , Hologic Daily , Hologic , Nasdaq Holx , Holx , Medical , 43644010 , Guidance , Earnings , Preannouncement ,
vimarsana.com © 2020. All Rights Reserved.